Does standard triple therapy still have a role in first-line Helicobacter pylori eradication in Korea?
Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
Hye Kyung
0000-0002-1550-7192
HK
Jeon
Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
Gwang Ha
0000-0001-9721-5734
GH
Kim
D000658:Amoxicillin / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D003140:Communicable Disease Control; D060740:Disease Eradication; D024881:Drug Resistance, Bacterial; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D056910:Republic of Korea; D014011:Tinidazole / Q000627:therapeutic use
D014011:Tinidazole; D008795:Metronidazole; D000658:Amoxicillin; D017291:Clarithromycin